Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in J Biol Chem

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    July 2017
  1. LO PK, Zhang Y, Yao Y, Wolfson B, et al
    Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFbeta signaling.
    J Biol Chem. 2017;292:11466-11484.
    PubMed     Text format     Abstract available


    June 2017
  2. SANDERS MA, Haynes B, Nangia-Makker P, Polin LA, et al
    Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
    J Biol Chem. 2017;292:10347-10363.
    PubMed     Text format     Abstract available


  3. TAN S, Ding K, Chong QY, Zhao J, et al
    Decreased miR26a/b and increased HuR expression post-transcriptionally upregulates ERBB2 to mediate acquired tamoxifen resistance in ER+ breast cancer cells.
    J Biol Chem. 2017 Jun 21. pii: jbc.M117.780973. doi: 10.1074/jbc.M117.780973.
    PubMed     Text format     Abstract available


    May 2017
  4. ROY A, Ansari SA, Das K, Prasad R, et al
    Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to beta-catenin accumulation via the AKT/GSK3beta pathway and contributes to breast cancer progression.
    J Biol Chem. 2017 May 18. pii: jbc.M116.764670. doi: 10.1074/jbc.M116.764670.
    PubMed     Text format     Abstract available


  5. MERCADO-MATOS J, Clark JL, Piper AJ, Janusis J, et al
    Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells.
    J Biol Chem. 2017;292:7806-7816.
    PubMed     Text format     Abstract available


  6. KERROS C, Tripathi SC, Zha D, Mehrens JM, et al
    Neuropilin-1 mediates Neutrophil Elastase uptake and cross-presentation in breast cancer cells.
    J Biol Chem. 2017 May 3. pii: jbc.M116.773051. doi: 10.1074/jbc.M116.773051.
    PubMed     Text format     Abstract available


    April 2017
  7. CHEN J, De Raeymaecker J, Hovgaard JB, Smaardijk S, et al
    Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca2+/Mn2+-transport ATPase (SPCA1a).
    J Biol Chem. 2017;292:6938-6951.
    PubMed     Text format     Abstract available


  8. MAJKOWSKA I, Shitomi Y, Ito N, Gray NS, et al
    Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts.
    J Biol Chem. 2017;292:6633-6643.
    PubMed     Text format     Abstract available


  9. JEONG J, VanHouten JN, Kim W, Dann P, et al
    The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.
    J Biol Chem. 2017;292:6555-6568.
    PubMed     Text format     Abstract available


  10. CHOO M, Tan HL, Ding V, Castangia R, et al
    Characterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4.
    J Biol Chem. 2017;292:6163-6176.
    PubMed     Text format     Abstract available


    March 2017
  11. OHOKA N, Okuhira K, Ito M, Nagai K, et al
    In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs).
    J Biol Chem. 2017;292:4556-4570.
    PubMed     Text format     Abstract available


  12. YAMAGUCHI N, Nakayama Y, Yamaguchi N
    Down-regulation of Forkhead Box Protein A1 (FOXA1) Leads to Cancer-stem Cell-like Properties in Tamoxifen-resistant Breast Cancer Cells through Induction of Interleukin-6.
    J Biol Chem. 2017 Mar 7. pii: jbc.M116.763276. doi: 10.1074/jbc.M116.763276.
    PubMed     Text format     Abstract available


    February 2017
  13. NAKANO M, Fukami T, Gotoh S, Nakajima M, et al
    A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    J Biol Chem. 2017 Feb 10. pii: jbc.M117.775684. doi: 10.1074/jbc.M117.775684.
    PubMed     Text format     Abstract available


    December 2016
  14. SCHAUWECKER SM, Kim JJ, Licht JD, Clevenger CV, et al
    Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-Induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells.
    J Biol Chem. 2016 Dec 29. pii: jbc.M116.764233. doi: 10.1074/jbc.M116.764233.
    PubMed     Text format     Abstract available


    November 2016
  15. ALEXANDER PB, Chen R, Gong C, Yuan L, et al
    Distinct receptor tyrosine kinase subsets mediate anti-HER2 drug resistance in breast cancer.
    J Biol Chem. 2016 Nov 30. pii: jbc.M116.754960.
    PubMed     Text format     Abstract available


  16. FANCY RM, Wang L, Schmid T, Zeng Q, et al
    Characterization of the interactions between calmodulin and death receptor 5 in triple-negative and estrogen receptor-positive breast cancer cells. AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.
    J Biol Chem. 2016;291:23489.
    PubMed     Text format    


  17. KO YH, Domingo-Vidal M, Roche M, Lin Z, et al
    TIGAR Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
    J Biol Chem. 2016 Nov 1. pii: jbc.M116.740209.
    PubMed     Text format     Abstract available


    October 2016
  18. ZHAO JJ, Lin J, Yang H, Kong W, et al
    MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.
    J Biol Chem. 2016;291:22859.
    PubMed     Text format    


  19. GUO JP, Shu SK, Esposito NN, Coppola D, et al
    IKK phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.
    J Biol Chem. 2016;291:22857.
    PubMed     Text format    


  20. KONG W, He L, Coppola M, Guo J, et al
    MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.
    J Biol Chem. 2016;291:22855.
    PubMed     Text format    


  21. CHANMEE T, Ontong P, Izumikawa T, Higashide M, et al
    Hyaluronan production regulates metabolic and cancer stem-like properties of breast cancer cells via hexosamine biosynthetic pathway-coupled HIF-1 signaling.
    J Biol Chem. 2016 Oct 6. pii: jbc.M116.751263.
    PubMed     Text format     Abstract available


    September 2016
  22. BEZAWORK-GELETA A, Dong L, Rohlena J, Neuzil J, et al
    The assembly factor SDHAF2 is dispensable for flavination of the catalytic subunit of mitochondrial complex II in breast cancer cells.
    J Biol Chem. 2016 Sep 1. pii: jbc.C116.755017.
    PubMed     Text format     Abstract available


    August 2016
  23. QIAO Y, He H, Jonsson P, Sinha I, et al
    AP-1 is a key regulator of proinflammatory cytokine TNFalpha-mediated triple-negative breast cancer progression.
    J Biol Chem. 2016;291:18309.
    PubMed     Text format    


  24. DUKEL M, Streitfeld WS, Tang TC, Backman LR, et al
    The Breast Cancer Tumor Suppressor TRIM29 is Expressed via ATM-Dependent Signaling in Response to Hypoxia.
    J Biol Chem. 2016 Aug 17. pii: jbc.M116.730960.
    PubMed     Text format     Abstract available


  25. HARRINGTON KM, Clevenger CV
    Identification of NEK3 Threonine 165 as a Novel Regulatory Phosphorylation Site that Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.
    J Biol Chem. 2016 Aug 3. pii: jbc.M116.726190.
    PubMed     Text format     Abstract available


    July 2016
  26. BOATENG LR, Bennin D, De Oliveira S, Huttenlocher A, et al
    Mammalian Actin-binding Protein-1/Hip-55 Interacts with FHL2 and Negatively Regulates Cell Invasion.
    J Biol Chem. 2016;291:13987-98.
    PubMed     Text format     Abstract available


    June 2016
  27. LIU HJ, Ooms LM, Srijakotre N, Man J, et al
    PREX1 Rac-GEF Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular-Signal-Regulated Kinase 1/2 (ERK1/2) Signaling.
    J Biol Chem. 2016 Jun 29. pii: jbc.M116.743401.
    PubMed     Text format     Abstract available


    May 2016
  28. COKE CJ, Scarlett KA, Chetram MA, Jones KJ, et al
    Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression.
    J Biol Chem. 2016;291:9991-10005.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: